TG Therapeutics
TGTX
TGTX
244 hedge funds and large institutions have $2.19B invested in TG Therapeutics in 2023 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 72 reducing their positions, and 30 closing their positions.
Holders
244
Holders Change
+31
Holders Change %
+14.55%
% of All Funds
3.85%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
61
Increased
73
Reduced
72
Closed
30
Calls
$144M
Puts
$97.6M
Net Calls
+$46.2M
Net Calls Change
+$25.4M
Top Buyers
| 1 |
1
Holocene Advisors
New York
|
$40.4M |
| 2 |
2
BlackRock
New York
|
$246M |
| 3 |
3
Allspring Global Investments
Charlotte,
North Carolina
|
$24.3M |
| 4 |
4
D.E. Shaw & Co
New York
|
$39.1M |
| 5 |
5
Man Group
London,
United Kingdom
|
$17.1M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
276
Capital Fund Management (CFM)
Paris,
France
| – | – | – | – |
|
277
Walleye Capital
New York
| – | – | – | – |
|
|
HT
278
HAP Trading
New York
| – | – | – | – |
|
|
BFM
279
Boothbay Fund Management
New York
| – | – | – | – |
|
|
IC
280
Ikarian Capital
Dallas,
Texas
| – | – | – | – |
|
|
O
281
OrbiMed
New York
| – | – | – | – |
|
|
CFGS
282
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|